CoChat
Sign Up
Cited by 177

The DOI matches its Crossref record.

PGRMC1 (progesterone receptor membrane component 1): A targetable protein with multiple functions in steroid signaling, P450 activation and drug binding

Rohe, Hannah J., Ahmed, Ikhlas S., Twist, Katherine E., Craven, Rolf J.·2009·Pharmacology & Therapeutics
DOI 10.1016/j.pharmthera.2008.09.006PMC PMC2659782
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2008.09.006

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 61

  1. Ace, 2004, Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase, Reprod Biol Endocrinol, 2, 54, 10.1186/1477-7827-2-54 · DOI
  2. Albro, 1978, Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid profiles in tissue of the Fischer rat, Chem Biol Interact, 23, 315, 10.1016/0009-2797(78)90093-5 · DOI
  3. Bard, 1978, Differences in crystal violet uptake and cation-induced death among yeast sterol mutants, J Bacteriol, 135, 1146, 10.1128/JB.135.3.1146-1148.1978 · DOI
  4. Bramley, 2002, Non-genomic steroid receptors in the bovine ovary, Domest Anim Endocrinol, 23, 3, 10.1016/S0739-7240(02)00140-6 · DOI
  5. Bruno, 2007, Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development, Bioorg Med Chem, 15, 5047, 10.1016/j.bmc.2007.05.046 · DOI
  6. Cahill, 2007, Progesterone receptor membrane component 1: an integrative review, J Steroid Biochem Mol Biol, 105, 16, 10.1016/j.jsbmb.2007.02.002 · DOI
  7. Cai, 2005, Expression and regulation of progestin membrane receptors in the rat corpus luteum, Endocrinology, 146, 5522, 10.1210/en.2005-0759 · DOI
  8. Carpenter, 2000, The EGF receptor: a nexus for trafficking and signaling, Bioessays, 22, 697, 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.0.CO;2-1 · DOI
  9. Cavalieri, 2000, Estrogens as endogenous genotoxic agents—DNA adducts and mutations, J Natl Cancer Inst Monogr, 75, 10.1093/oxfordjournals.jncimonographs.a024247 · DOI
  10. Craven, 2007, Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51, J Biol Chem, 282, 36543, 10.1074/jbc.M706770200 · DOI
  11. Crudden, 2006, Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs, J Pharmacol Exp Ther, 316, 448, 10.1124/jpet.105.094631 · DOI
  12. Crudden, 2005, Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors, Tumour Biol, 26, 142, 10.1159/000086485 · DOI
  13. Debose-Boyd, 2007, A helping hand for cytochrome p450 enzymes, Cell Metab, 5, 81, 10.1016/j.cmet.2007.01.007 · DOI
  14. Difilippantonio, 2003, Gene expression profiles in human non-small and small-cell lung cancers, Eur J Cancer, 39, 1936, 10.1016/S0959-8049(03)00419-2 · DOI
  15. Dressman, 2006, Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy, Clin Cancer Res, 12, 819, 10.1158/1078-0432.CCR-05-1447 · DOI · Paper page
  16. Franco, 2005, Effectors of mammalian telomere dysfunction: a comparative transcriptome analysis using mouse models, Carcinogenesis, 26, 1613, 10.1093/carcin/bgi107 · DOI
  17. Gaisne, 1999, A ‘natural’ mutation in Saccharomyces cerevisiae strains derived from S288c affects the complex regulatory gene HAP1 (CYP1), Curr Genet, 36, 195, 10.1007/s002940050490 · DOI
  18. Gerdes, 1998, Cloning and tissue expression of two putative steroid membrane receptors, Biol Chem, 379, 907
  19. Ghosh, 2005, Spectroscopic and biochemical characterization of heme binding to yeast Dap1p and mouse PGRMC1p, Biochemistry, 44, 16729, 10.1021/bi0511585 · DOI
  20. Goldstein, 2006, Protein sensors for membrane sterols, Cell, 124, 35, 10.1016/j.cell.2005.12.022 · DOI · Paper page
  21. Hand, 2003, Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells, J Cell Biochem, 90, 534, 10.1002/jcb.10648 · DOI
  22. Hand, 2003, Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor, Eukaryot Cell, 2, 306, 10.1128/EC.2.2.306-317.2003 · DOI
  23. Hokaiwado, 2004, Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system, Cancer Sci, 95, 123, 10.1111/j.1349-7006.2004.tb03192.x · DOI
  24. Hughes, 2007, Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes, Cell Metab, 5, 143, 10.1016/j.cmet.2006.12.009 · DOI · Paper page
  25. Irby, 2005, Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype, Cancer Res, 65, 1814, 10.1158/0008-5472.CAN-04-3609 · DOI
  26. Kimura, 2008, Neurotrophic activity of neudesin, a novel extracellular heme-binding protein, is dependent on the binding of heme to its cytochrome b5-like heme/steroid-binding domain, J Biol Chem, 283, 4323, 10.1074/jbc.M706679200 · DOI
  27. Kociba, 1978, Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats, Toxicol Appl Pharmacol, 46, 279, 10.1016/0041-008X(78)90075-3 · DOI
  28. Krebs, 2000, A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors, Proc Natl Acad Sci U S A, 97, 12816, 10.1073/pnas.97.23.12816 · DOI
  29. Labombarda, 2003, Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord, J Neurochem, 87, 902, 10.1046/j.1471-4159.2003.02055.x · DOI
  30. Laird, 1988, Monoclonal antibodies against rat adrenocortical cell antigens, Acta Endocrinol (Copenh), 119, 420, 10.1530/acta.0.1190420 · DOI
  31. Lepesheva, 2007, Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms, Biochim Biophys Acta, 1770, 467, 10.1016/j.bbagen.2006.07.018 · DOI
  32. Losel, 2007, Progesterone receptor membrane component 1—many tasks for a versatile protein, Steroids
  33. Lum, 2004, Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes, Cell, 116, 121, 10.1016/S0092-8674(03)01035-3 · DOI
  34. Mallory, 2005, Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p/Cyp51p in Saccharomyces cerevisiae, Mol Cell Biol, 25, 1669, 10.1128/MCB.25.5.1669-1679.2005 · DOI
  35. Mallory, 2005, A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells, Mol Pharmacol, 68, 1747, 10.1124/mol.105.016519 · DOI
  36. Meffre, 2005, The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury, J Neurochem, 93, 1314, 10.1111/j.1471-4159.2005.03127.x · DOI
  37. Meyer, 1996, Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes, Eur J Biochem, 239, 726, 10.1111/j.1432-1033.1996.0726u.x · DOI
  38. Meyer, 1998, Are high-affinity progesterone binding site(s) from porcine liver microsomes members of the sigma receptor family?, Eur J Pharmacol, 347, 293, 10.1016/S0014-2999(98)00103-4 · DOI
  39. Mifsud, 2002, Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain, Genome Biol, 3, 10.1186/gb-2002-3-12-research0068 · DOI
  40. Min, 2005, Molecular identification of adrenal inner zone antigen as a heme-binding protein, Febs J, 272, 5832, 10.1111/j.1742-4658.2005.04977.x · DOI
  41. Min, 2004, Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis, Mol Cell Endocrinol, 215, 143, 10.1016/j.mce.2003.11.025 · DOI
  42. Nebert, 1970, Genetic differences in the extent of aryl hydrocarbon hydroxylase induction in mouse fetal cell cultures, J Biol Chem, 245, 6373, 10.1016/S0021-9258(18)62620-1 · DOI
  43. Nie, 2006, Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity, Mol Carcinog, 45, 914, 10.1002/mc.20205 · DOI
  44. Nilsson, 2006, Interactions between progesterone and tumor necrosis factor-alpha in the regulation of primordial follicle assembly, Reproduction, 132, 877, 10.1530/REP-06-0045 · DOI
  45. Nolte, 2000, Localization and topology of ratp28, a member of a novel family of putative steroid-binding proteins, Biochim Biophys Acta, 1543, 123, 10.1016/S0167-4838(00)00188-6 · DOI
  46. Okamoto, 1998, Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane, J Biol Chem, 273, 5419, 10.1074/jbc.273.10.5419 · DOI
  47. Peluso, 2008, Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1, J Clin Endocrinol Metab, 93, 1592, 10.1210/jc.2007-2771 · DOI
  48. Peluso, 2006, Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action, Endocrinology, 147, 3133, 10.1210/en.2006-0114 · DOI
  49. Peluso, 2008, Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations, Endocrinology, 149, 534, 10.1210/en.2007-1050 · DOI
  50. Raza, 2001, Identification of the rat adrenal zona fasciculata/reticularis specific protein, inner zone antigen (IZAg), as the putative membrane progesterone receptor, Eur J Biochem, 268, 2141, 10.1046/j.1432-1327.2001.02096.x · DOI
  51. Sakamoto, 2004, Expression and localization of 25-Dx, a membrane-associated putative progesterone-binding protein, in the developing Purkinje cell, Neuroscience, 126, 325, 10.1016/j.neuroscience.2004.04.003 · DOI
  52. Schenkman, 2003, The many roles of cytochrome b5, Pharmacol Ther, 97, 139, 10.1016/S0163-7258(02)00327-3 · DOI
  53. Schumacher, 2007, Progesterone: therapeutic opportunities for neuroprotection and myelin repair, Pharmacol Ther, 116, 77, 10.1016/j.pharmthera.2007.06.001 · DOI
  54. Selmin, 1996, Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver, Carcinogenesis, 17, 2609, 10.1093/carcin/17.12.2609 · DOI
  55. Selmin, 2005, Transcriptional activation of the membrane-bound progesterone receptor (mPR) by dioxin, in endocrine-responsive tissues, Mol Reprod Dev, 70, 166, 10.1002/mrd.20090 · DOI
  56. Shridhar, 2001, Genetic analysis of early- versus late-stage ovarian tumors, Cancer Res, 61, 5895
  57. Suchanek, 2005, Photo-leucine and photo-methionine allow identification of protein–protein interactions in living cells, Nat Methods, 2, 261, 10.1038/nmeth752 · DOI
  58. Thompson, 2007, Measurement of the heme affinity for yeast Dap1p, and its importance in cellular function, Biochemistry, 46, 14629, 10.1021/bi7013739 · DOI
  59. Wei, 2006, Prognostic DNA methylation biomarkers in ovarian cancer, Clin Cancer Res, 12, 2788, 10.1158/1078-0432.CCR-05-1551 · DOI
  60. Yang, 2002, Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER, Cell, 110, 489, 10.1016/S0092-8674(02)00872-3 · DOI · Paper page
  61. Zajchowski, 2002, Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains, Eur J Biochem, 269, 737, 10.1046/j.0014-2956.2001.02715.x · DOI

Cited by

Sorted by citations

Metadata

Authors
Rohe, H. J., Ahmed, I. S., Twist, K. E., & Craven, R. J.
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2009-01
Volume
121
Issue
1
Pages
14-19
ISSN
0163-7258
DOI
10.1016/j.pharmthera.2008.09.006
PMC
PMC2659782
Cited by
177
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review